X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13217) 13217
Newsletter (117) 117
Newspaper Article (12) 12
Dissertation (6) 6
Magazine Article (6) 6
Publication (2) 2
Report (2) 2
Book Chapter (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11926) 11926
etoposide - administration & dosage (9260) 9260
male (8077) 8077
antineoplastic combined chemotherapy protocols - therapeutic use (8035) 8035
female (7640) 7640
oncology (6448) 6448
middle aged (6237) 6237
adult (6105) 6105
etoposide (4836) 4836
aged (4549) 4549
chemotherapy (4350) 4350
cisplatin - administration & dosage (4084) 4084
treatment outcome (2947) 2947
antineoplastic combined chemotherapy protocols - adverse effects (2939) 2939
cyclophosphamide - administration & dosage (2866) 2866
cancer (2551) 2551
combined modality therapy (2513) 2513
antineoplastic combined chemotherapy protocols - administration & dosage (2473) 2473
adolescent (2449) 2449
lung neoplasms - drug therapy (2415) 2415
doxorubicin - administration & dosage (2343) 2343
vincristine - administration & dosage (2194) 2194
hematology (2148) 2148
cisplatin (2047) 2047
etoposide - adverse effects (1928) 1928
drug administration schedule (1836) 1836
carboplatin - administration & dosage (1762) 1762
prognosis (1668) 1668
remission induction (1608) 1608
survival rate (1578) 1578
child (1441) 1441
bleomycin - administration & dosage (1413) 1413
cytarabine - administration & dosage (1399) 1399
survival analysis (1373) 1373
ifosfamide - administration & dosage (1361) 1361
disease-free survival (1340) 1340
neoplasm staging (1309) 1309
therapy (1302) 1302
carcinoma, small cell - drug therapy (1293) 1293
retrospective studies (1231) 1231
etoposide - therapeutic use (1144) 1144
cyclophosphamide (1129) 1129
child, preschool (1126) 1126
follow-up studies (1125) 1125
carboplatin (1050) 1050
methotrexate - administration & dosage (1049) 1049
care and treatment (934) 934
prednisone - administration & dosage (923) 923
transplantation (909) 909
lung neoplasms - pathology (896) 896
aged, 80 and over (895) 895
carcinoma (885) 885
dose-response relationship, drug (869) 869
survival (869) 869
animals (859) 859
pharmacology & pharmacy (841) 841
infant (827) 827
trial (824) 824
tumors (819) 819
salvage therapy (810) 810
cisplatin - adverse effects (790) 790
radiotherapy (785) 785
antineoplastic agents - administration & dosage (779) 779
transplantation, autologous (774) 774
prospective studies (754) 754
carcinoma, non-small-cell lung - drug therapy (748) 748
doxorubicin (743) 743
recurrence (737) 737
antineoplastic agents, phytogenic - administration & dosage (719) 719
time factors (715) 715
medicine & public health (702) 702
hematopoietic stem cell transplantation (700) 700
lung neoplasms - mortality (698) 698
administration, oral (685) 685
combination chemotherapy (680) 680
young adult (677) 677
testicular neoplasms - drug therapy (664) 664
phase-ii (658) 658
children (655) 655
pediatrics (651) 651
lymphoma, non-hodgkin - drug therapy (638) 638
research (637) 637
vinblastine - administration & dosage (637) 637
ifosfamide (594) 594
etoposide - pharmacology (593) 593
toxicity (580) 580
chemotherapy, adjuvant (572) 572
risk factors (550) 550
bone-marrow transplantation (543) 543
lung neoplasms - radiotherapy (543) 543
cyclophosphamide - adverse effects (537) 537
antineoplastic agents - therapeutic use (535) 535
combination (529) 529
infusions, intravenous (529) 529
paclitaxel - administration & dosage (521) 521
high-dose chemotherapy (520) 520
mice (516) 516
bone marrow transplantation (515) 515
paclitaxel (513) 513
surgery (502) 502
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12316) 12316
Japanese (939) 939
German (168) 168
French (144) 144
Chinese (103) 103
Spanish (63) 63
Russian (44) 44
Polish (39) 39
Italian (26) 26
Hungarian (16) 16
Portuguese (16) 16
Dutch (6) 6
Serbian (6) 6
Czech (4) 4
Hebrew (3) 3
Danish (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 15, pp. 1408 - 1416
A dose-intense infusional chemotherapy program plus rituximab had a high degree of efficacy in patients with primary mediastinal B-cell lymphoma, which is... 
MEDICINE, GENERAL & INTERNAL | AMPLIFICATION | MANAGEMENT | EFFICACY | DOXORUBICIN | SCLEROSIS | CLASSICAL HODGKIN LYMPHOMA | RADIOTHERAPY | EXPRESSION | GERMINAL-CENTER | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Filgrastim | Dose-Response Relationship, Drug | Young Adult | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Kaplan-Meier Estimate | Rituximab | Stroke Volume - drug effects | Etoposide - administration & dosage | Recombinant Proteins - administration & dosage | Disease-Free Survival | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Dose-response relationship (Biochemistry) | Usage | Cyclophosphamide | Patient outcomes | Dosage and administration | Lymphomas | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Doxorubicin | Medical research | Nuclear magnetic resonance--NMR | Disease | Review boards | Genes | Etoposide | Prednisone | Radiation therapy | Kinases | Vincristine | Patients | Morbidity | Chemotherapy | Lymphocytes B | Remission | Mutation | Hodgkin's disease | B-cell lymphoma
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
.... We aimed to show the superiority of the neoadjuvant administration of histotype-tailored regimen to standard chemotherapy... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 27, pp. 4199 - 4206
Journal Article
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2009 - 2017
Summary Background Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IDARUBICIN | THERAPY | DOSE ARA-C | PEDIATRIC-PATIENTS | SENSITIVITY | RISK | CHILDHOOD LEUKEMIA | EXPERIENCE | ACCELERATED APPROVAL | ONCOLOGY GROUP | Recurrence | Cyclophosphamide - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Female | Leukocyte Count | Child | Idarubicin - therapeutic use | Mitoxantrone - therapeutic use | Dexamethasone - administration & dosage | Risk Assessment | Kaplan-Meier Estimate | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | United Kingdom | Vidarabine - analogs & derivatives | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Vidarabine - administration & dosage | Complications and side effects | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Patient outcomes | Mitoxantrone hydrochloride | Studies | Design | Medical research | Chemotherapy | Databases | Cytogenetics | Cancer therapies | Cancer | Ovarian cancer
Journal Article
Cochrane library, ISSN 1469-493X, 06/2016, Volume 2019, Issue 9, p. CD007102
Background This is the second update of a Cochrane review that was first published in 2009, Issue 1. Gestational trophoblastic neoplasia (GTN) is a rare but... 
Trophoblastic | Drug Administration Schedule | Antineoplastic Agents | Risk | Leucovorin | Dactinomycin | Gestational trophoblastic neoplasia | Randomized Controlled Trials as Topic | Gynaecology | Gynaecological | MISCELLANEOUS GYNAECOLOGICAL CANCER TOPICS | Gestational Trophoblastic Disease | Vitamin B Complex | Case‐Control Studies | Methotrexate | Medicine General & Introductory Medical Sciences | Cohort Studies | Cancer | Vitamin B Complex [administration & dosage] | Methotrexate [administration & dosage; adverse effects] | Humans | Antineoplastic Agents [administration & dosage; adverse effects] | FOLINIC ACID | Case-Control Studies | Leucovorin [administration & dosage] | MEDICINE, GENERAL & INTERNAL | CITROVORUM FACTOR RESCUE | PHASE-II TRIAL | Dactinomycin [administration & dosage; adverse effects] | WEEKLY INTRAMUSCULAR METHOTREXATE | Gestational Trophoblastic Disease [drug therapy] | Female | LOW-DOSE METHOTREXATE | SINGLE-AGENT METHOTREXATE | 5-DAY METHOTREXATE | Pregnancy | DISEASE | ORAL ETOPOSIDE | PULSE ACTINOMYCIN-D | Leucovorin - administration & dosage | Dactinomycin - administration & dosage | Antineoplastic Agents - administration & dosage | Vitamin B Complex - administration & dosage | Methotrexate - adverse effects | Antineoplastic Agents - adverse effects | Dactinomycin - adverse effects | Methotrexate - administration & dosage | Gestational Trophoblastic Disease - drug therapy
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2005, Volume 23, Issue 36, pp. 9198 - 9207
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2013, Volume 31, Issue 2, pp. 231 - 239
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy... 
INHIBIN-B | PRESERVATION | OUTCOME MEASURE | OVARIAN RESERVE | ONCOLOGY | TERM FOLLOW-UP | DISEASE | FEMALE CANCER SURVIVORS | ANTI-MULLERIAN HORMONE | CHEMOTHERAPY | SERUM MARKER | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility - physiology | Fertility Preservation | Young Adult | Vinblastine - adverse effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Oligospermia - epidemiology | Vincristine - administration & dosage | Adult | Female | Gonadotropin-Releasing Hormone - therapeutic use | Hodgkin Disease - physiopathology | Inhibins - blood | Menstrual Cycle - drug effects | Testosterone - blood | Menstrual Cycle - physiology | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - administration & dosage | Ovary - physiology | Hodgkin Disease - epidemiology | Bleomycin - administration & dosage | Bleomycin - adverse effects | Germany - epidemiology | Randomized Controlled Trials as Topic | Pregnancy | Testis - physiology | Hodgkin Disease - blood | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Index Medicus
Journal Article
Journal Article